Skip to main content
Premium Trial:

Request an Annual Quote

Serologicals Chemicon Arm Licenses RhoeGene s RheoSwitch System

NEW YORK, Nov. 29 (GenomeWeb News) - Serologicals subsidiary Chemicon International signed a semi-exclusive license to use RheoGene's RheoSwitch System for its stem cell biology products, Serologicals said yesterday.

 

Under this agreement, Chemicon can access the RheoSwitch technology to regulate the timing and level of gene expression in all types of eukaryotic cells. RheoGene will provide proprietary ecdysone-based receptors and molecule ligands for the system. Chemicon will apply the technology to generic cloning and expression reagents and to genes involved in cell differentiation.

 

Financial terms were not disclosed.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.